Endocrine safety of ulipristal acetate, a selective progesterone receptor modulator (SPRM): results from two phase II randomised, placebo‐controlled studies.

Non ancora tradotto Non ancora tradotto
Categoria Primary study
GiornaleEndocrine Abstracts
Year 2010
Loading references information
Questo articolo non ha abstract
Epistemonikos ID: 3535d0460947655b843cdb24060ede5d7cdd1ede
First added on: May 08, 2020